R19.6
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Halitosis of intra-oral origin with daily periods of noticeable bad breath; otherwise healthy in the opinion of the investigator.
Exclusion criteria
Exclusion criteria: History of allergic or undesirable reactions to ingredients of study treatment; pregnancy, breast-feeding or planned pregnancy during the study. Lack of suitability for the study: Extra-oral halitosis; Oropharyngeal diseases affording treatmentund; Medical history of infectious diseases; Medical history of malignant diseases. Systemic medication related to oral dryness; Systemic antibiotic therapy within the preceding three months of the study; Current smoker; Current drug or alcohol abuse.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the efficacy of a 30 second mouthwash with 10 mL MEDA03164 mouthwash to the efficacy of a 30 second mouthwash with 10 mL water (morning assessment 12 hours after rinsing the mouth) based on OralChroma measurements (hydrogen sulphide) and organoleptic scoring of mouth odour strength according to Rosenberg/Greenman. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the efficacy of a 30 second mouthwash with 10 mL MEDA03164 mouthwash to the efficacy of a 30 second mouthwash with 10 mL water (morning assessment 12 hours after rinsing the mouth) based on OralChroma (Dimethyle sulphide) and Halimeter measurements of volatile sulphur compounds. To compare the efficacy of a 30 second mouthwash with 10 mL MEDA03164 mouthwash to the efficacy of a 30 second mouthwash with 10 mL water (evening assessment 12 hours after rinsing the mouth a second time) based on OralChroma measurements, organoleptic scoring of the mouth odour strength according to Rosenberg/Greenman and Halimeter measurements. | — |
Countries
Germany
Contacts
Meda Pharma GmbH & Co KG (a Mylan company), Scientific Affairs, Clinical Affairs Meda